SPRY ARS Pharmaceuticals, Inc.
$5.67▼ -1.56%
Unknown
Other
Last sync: just now
Syncing
Key Metrics & Fundamentals
Market Cap
$563.05M
P/E Ratio
–
Div Yield
–%
52W Range
5.62 - 18.50
% vs 50 MA
-30.14%
% vs 200 MA
-36.50%
RSI-14
24.0
MACD Histogram
-0.1600
Beta (1Y vs SPY)
1.52
Gross Rev
$98.99M
Gross Profit
$58.81M
EBITDA
-$200.93M
COGS
$40.18M
Operating Exp
$259.74M
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Volume (M)
Financial Overview - Income Statement
Quarterly
Jun 2026 (Quarterly)
Social Sentiment
Avg +0.64 · 10 posts
DDNewsDiscussionPriceTargetARS Pharma (SPRY)—are the insiders right, or is the market right?
r/wallstreetbets · May 13, 2026
Insider selling is viewed negatively, but a drying up of sales combined with good news suggests a potential upward trend. The 'betting it will fall further' sentiment contrasts with the author's optimism.
positive
+0.60
DDDiscussionI’m a nurse. And I love this product. I think this company is the next big thing.
r/wallstreetbets · Oct 13, 2025
The author strongly advocates for the company and highlights key product advantages.
very_positive
+0.90
DDNewsDiscussion🚨 $AQST DD 🚨 Battle of the Drug Dealers: $AQST vs $SPRY vs Epipen (FDA Jan 31 Catalyst)
r/wallstreetbets · Sep 24, 2025
SPRY is actively discussed alongside AQST in the post.
positive
+0.50
DDNewsTradeSPRY Gains
r/wallstreetbets · Feb 28, 2025
The post expresses a positive view of the stock due to favorable news and a low P/E ratio.
positive
+0.60
DDNewsDiscussionARS Pharmaceuticals, Inc. (SPRY)
r/wallstreetbets · Oct 3, 2024
The post discusses the benefits and potential of SPRY's epinephrine nasal spray, presenting it as a favorable alternative to traditional EpiPens.
positive
+0.60
Page 1 of 2 (10 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not Financial Advice.
All data, scores, charts, and analysis on this site are provided for informational and educational purposes only
and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
Always consult a qualified financial advisor before making any investment decisions.
See our Legal Notice for full details.